MCCC2
Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial
Also known as: MCCB, MCCB_HUMAN, MCCCbeta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCC0
- Gene
- MCCC2
- Ensembl
- ENSG00000131844
- Chromosome
- 5
- Canonical length
- 563 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes the small subunit of 3-methylcrotonyl-CoA carboxylase. This enzyme functions as a heterodimer and catalyzes the carboxylation of 3-methylcrotonyl-CoA to form 3-methylglutaconyl-CoA. Mutations in this gene are associated with 3-Methylcrotonylglycinuria, an autosomal recessive disorder of leucine catabolism. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2018]
Canonical amino-acid sequenceUniProt
563 residues, UniProt reviewed canonical sequence.
>Q9HCC0|MCCC2
1 MWAVLRLALR PCARASPAGP RAYHGDSVAS LGTQPDLGSA LYQENYKQMK ALVNQLHERV
61 EHIKLGGGEK ARALHISRGK LLPRERIDNL IDPGSPFLEL SQFAGYQLYD NEEVPGGGII
121 TGIGRVSGVE CMIIANDATV KGGAYYPVTV KKQLRAQEIA MQNRLPCIYL VDSGGAYLPR
181 QADVFPDRDH FGRTFYNQAI MSSKNIAQIA VVMGSCTAGG AYVPAMADEN IIVRKQGTIF
241 LAGPPLVKAA TGEEVSAEDL GGADLHCRKS GVSDHWALDD HHALHLTRKV VRNLNYQKKL
301 DVTIEPSEEP LFPADELYGI VGANLKRSFD VREVIARIVD GSRFTEFKAF YGDTLVTGFA
361 RIFGYPVGIV GNNGVLFSES AKKGTHFVQL CCQRNIPLLF LQNITGFMVG REYEAEGIAK
421 DGAKMVAAVA CAQVPKITLI IGGSYGAGNY GMCGRAYSPR FLYIWPNARI SVMGGEQAAN
481 VLATITKDQR AREGKQFSSA DEAALKEPII KKFEEEGNPY YSSARVWDDG IIDPADTRLV
541 LGLSFSAALN APIEKTDFGI FRMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MCCC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 110 nTPM
Expression across tissuesHPA
Tissue
- liver: 110 nTPM
- kidney: 68 nTPM
- heart muscle: 51 nTPM
- breast: 47 nTPM
- prostate: 39 nTPM
- thyroid gland: 39 nTPM
Single-cell type
- endometrial luminal cells: 150 nCPM
- breast lactating cells: 132 nCPM
- prostatic glandular cells: 124 nCPM
- hepatocytes: 115 nCPM
- parietal cells: 110 nCPM
- syncytiotrophoblasts: 96 nCPM
Immune cell
- myeloid DC: 14 nTPM
- NK-cell: 11 nTPM
- intermediate monocyte: 9.8 nTPM
- T-reg: 7.5 nTPM
- total PBMC: 6.1 nTPM
- naive CD8 T-cell: 5.8 nTPM
Brain region
- choroid plexus: 20 nTPM
- white matter: 15 nTPM
- spinal cord: 12 nTPM
- medulla oblongata: 9.2 nTPM
- thalamus: 9 nTPM
- cerebellum: 8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MCCC2.
Disease | AllUniProt
Conditions MCCC2 is implicated in, by any mechanism.
- 3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) MIM:210210
Disease | GeneticClinVar
198 pathogenic / likely-pathogenic of 915 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- 3-methylcrotonyl-CoA carboxylase 2 deficiency
- Methylcrotonyl-CoA carboxylase deficiency
- MCCC2-related disorder
- Inborn genetic diseases
- Autism spectrum disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acetyl-coenzyme A carboxyltransferase, N-terminal
- Acetyl-coenzyme A carboxyltransferase, C-terminal
- ClpP/crotonase-like domain superfamily
- Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
- Carboxyl transferase domain
- Methylcrotonoyl-CoA carboxylase beta chain MCCB/AccD1-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MCCC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MCCC2 as an antibody target. Whether an autoantibody or antibody against MCCC2 could matter depends on whether native MCCC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MCCC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MCCC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...